Brief: Shanghai Junshi Biosciences Sees 2023 Net Loss Of 2.3 Bln Yuan
Jan 30 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* SAYS IT EXPECTS NET LOSS TO NARROW TO 2.3 BILLION YUAN
($320.42
million) IN 2023
Source text
Further company coverage: 688180.SS
($1 = 7.1781 Chinese yuan renminbi)
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab